Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide
C12H29N4O4P — CID 141315652
Data last refreshed: (MolForge compound catalog, from PubChem)
About Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide
Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide (PubChem CID 141315652) has the molecular formula C12H29N4O4P and a molecular weight of 324.36 g/mol. Its IUPAC name is diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide.
Molecular Properties
| Compound Name | Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide |
|---|---|
| PubChem CID | 141315652 |
| Molecular Formula | C12H29N4O4P |
| Molecular Weight | 324.36 g/mol |
| Exact Mass | 324.19 |
| IUPAC Name | diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide |
| SMILES | CC(=O)N[C@@H](C(C)C)[C@H]1CC=C(P(=O)([O-])[O-])C[C@@H]1N.[NH4+].[NH4+] |
| InChI | InChI=1S/C12H23N2O4P.2H3N/c1-7(2)12(14-8(3)15)10-5-4-9(6-11(10)13)19(16,17)18;;/h4,7,10-12H,5-6,13H2,1-3H3,(H,14,15)(H2,16,17,18);2*1H3/t10-,11-,12-;;/m0../s1 |
| InChIKey | LXRHHAYTKSDAQG-MGKSKXMVSA-N |
| XLogP | 0.43 |
| TPSA | 191.31 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 324.36 |
| LogP ≤ 5 | 0.43 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141315652 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.